// App-Quantinova.ai

319 : A Pragmatic Randomized Trial to Improve Safe Dosing of Hydroxychloroquine

Researchers

Presenter

  • Sara Murray

Principal Investigators

  • Michael Evans

  • Gabriela Schmajuk

  • Jinoos Yazdany

Medical Centers

  • University of California, San Francisco, San Francisco, CA

  • University of California, San Francisco, San Francisco, CA

  • UCSF, SFVAMC Division of Rheumatology, San Francisco, CA

  • UCSF, SFVAMC Division of Rheumatology, San Francisco, CA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • N/A

Disease

  • N/A

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

Outcome

  • N/A

Study Design

  • Randomized

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved